[HTML][HTML] Clozapine: an updated overview of pharmacogenetic biomarkers, risks, and safety—particularities in the context of COVID-19

AM Dragoi, I Radulescu, BA Năsui, AL Pop, VN Varlas… - Brain sciences, 2020 - mdpi.com
Background: clozapine (CLZ) use is precarious due to its neurological, cardiovascular, and
hematological side effects; however, it is the gold standard in therapy-resistant …

Optimizing care for people experiencing homelessness and serious mental Illness amidst COVID-19: A street outreach perspective

Y Wynn, V Stergiopoulos - Journal of Health Care for the Poor and …, 2021 - muse.jhu.edu
The COVID-19 pandemic has disproportionately affected marginalized individuals with
multiple vulnerabilities, including those experiencing serious mental illness and …

Starting clozapine in patients with schizophrenia during the ongoing pandemic

S Grover, C Naskar, S Sahoo, A Mehra… - Schizophrenia …, 2022 - Elsevier
Clozapine is one of the most effective antipsychotics in patients with treatment resistant
schizophrenia. However, during the ongoing pandemic some of the reports suggest that …

Drugs for COVID-19: Revealing Mechanisms of Action, Adverse Reactions, and Solutions

Q Dong, P Lin, J Yi, X Kong… - American …, 2023 - journals.publicknowledgeproject.org
Abstract Novel coronavirus disease (COVID-19) is highly transmissible, easily spreadable,
and characterized by multiple pathologies. To date, the virus has undergone many …

Clozapine and COVID-19/respond

WG Honer, CU Correll, A Hasan… - … of Psychiatry & …, 2020 - search.proquest.com
any discussion of clozapine and agranulocytosis risk must be couched in a historical
perspective. Competing interests: G. Remington has received clinical, research and advisory …

A New Model of SARS-CoV-2 Infection Based on (Hydroxy) Chloroquine Activity

RJ Sheaff - bioRxiv, 2020 - biorxiv.org
Chloroquine and hydroxychloroquine (H) CQ are well known anti-malarial drugs, while their
use against COVID-19 is more controversial.(H) CQ activity was examined in tissue culture …

Clozapine and COVID-19: The authors respond.

D Siskind, WG Honer, S Clark, CU Correll… - Journal of psychiatry …, 2020 - europepmc.org
We compliment the authors and journal for ensuring the “Consensus statement on the use of
clozapine during the COVID-19 pandemic” was published in a timely fashion. 1 Coronavirus …